Department of Psychology, University of California, Davis, Davis, California.
Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Princeton Neuroscience Institute, Princeton, New Jersey.
Biol Psychiatry. 2022 Dec 15;92(12):942-951. doi: 10.1016/j.biopsych.2022.06.030. Epub 2022 Jul 5.
Major depressive disorder is one of the most commonly diagnosed mental illnesses worldwide, with a higher prevalence in women than in men. Although currently available pharmacological therapeutics help many individuals, they are not effective for most. Animal models have been important for the discovery of molecular alterations in stress and depression, but difficulties in adapting animal models of depression for females has impeded progress in developing novel therapeutic treatments that may be more efficacious for women.
Using the California mouse social defeat model, we took a multidisciplinary approach to identify stress-sensitive molecular targets that have translational relevance for women. We determined the impact of stress on transcriptional profiles in male and female California mouse nucleus accumbens (NAc) and compared these results with data from postmortem samples of the NAc from men and women diagnosed with major depressive disorder.
Our cross-species computational analyses identified Rgs2 (regulator of G protein signaling 2) as a transcript downregulated by social defeat stress in female California mice and in women with major depressive disorder. RGS2 plays a key role in signal regulation of neuropeptide and neurotransmitter receptors. Viral vector-mediated overexpression of Rgs2 in the NAc restored social approach and sucrose preference in stressed female California mice.
These studies show that Rgs2 acting in the NAc has functional properties that translate to changes in anxiety- and depression-related behavior. Future studies should investigate whether targeting Rgs2 represents a novel target for treatment-resistant depression in women.
重度抑郁症是全球最常见的精神疾病之一,女性的患病率高于男性。尽管目前可用的药物治疗方法对许多人有帮助,但对大多数人来说并不有效。动物模型对于发现应激和抑郁中的分子改变非常重要,但由于难以适应女性抑郁动物模型,因此在开发可能对女性更有效的新型治疗方法方面进展缓慢。
我们使用加利福尼亚小鼠社交挫败模型,采取多学科方法来确定具有女性相关性的应激敏感分子靶标。我们确定了应激对雄性和雌性加利福尼亚小鼠伏隔核(NAc)转录谱的影响,并将这些结果与来自被诊断患有重度抑郁症的男性和女性 NAc 死后样本的数据进行了比较。
我们的跨物种计算分析将 Rgs2(G 蛋白信号转导调节因子 2)鉴定为雌性加利福尼亚小鼠和患有重度抑郁症的女性中受社交挫败应激下调的转录本。RGS2 在神经肽和神经递质受体的信号调节中起关键作用。在 NAc 中过表达 Rgs2 的病毒载体恢复了应激雌性加利福尼亚小鼠的社交接近和蔗糖偏好。
这些研究表明,NAc 中的 Rgs2 具有可转化为焦虑和抑郁相关行为变化的功能特性。未来的研究应探讨靶向 Rgs2 是否代表女性治疗抵抗性抑郁症的新靶点。